A Bertani

Summary

Affiliation: San Raffaele Scientific Institute
Country: Italy

Publications

  1. ncbi request reprint Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study
    A Bertani
    Anxiety Disorder Clinical and Research Unit, Department of Neuropsychiatric Sciences, Vita Salute University, Istituto Scientifico Ospedale San Raffaele, Milan, Italy
    Pharmacopsychiatry 37:206-10. 2004
  2. ncbi request reprint A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study
    G Perna
    Department of Neuropsychiatric Sciences, University Vita e Salute, Istituto Scientifico Ospedale San Raffaele, Milan, Italy
    Pharmacopsychiatry 34:85-90. 2001
  3. ncbi request reprint The 35% CO2 hyperreactivity and clinical symptomatology in patients with panic disorder after 1 week of treatment with citalopram: an open study
    A Bertani
    Department of Neuropsychiatric Sciences, University of Milan, Istituto Scientifico HS Raffaele, Italy
    J Clin Psychopharmacol 21:262-7. 2001
  4. ncbi request reprint Does the brain noradrenaline network mediate the effects of the CO2 challenge?
    L Bellodi
    Anxiety Disorders Clinical and Research Unit, Department of Neuropsychiatric Sciences, Vita Salute University, Istituto Scientifico HS Raffaele, Milan, Italy
    J Psychopharmacol 17:263-4; discussion 267-8. 2003

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study
    A Bertani
    Anxiety Disorder Clinical and Research Unit, Department of Neuropsychiatric Sciences, Vita Salute University, Istituto Scientifico Ospedale San Raffaele, Milan, Italy
    Pharmacopsychiatry 37:206-10. 2004
    ..However preliminary studies suggested that reboxetine might be effective in the treatment of PD. We compared the effectiveness and tolerability of reboxetine and paroxetine in the treatment of PD...
  2. ncbi request reprint A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study
    G Perna
    Department of Neuropsychiatric Sciences, University Vita e Salute, Istituto Scientifico Ospedale San Raffaele, Milan, Italy
    Pharmacopsychiatry 34:85-90. 2001
    ..In this class of drugs, citalopram is the most selective for serotonin. We compared these two drugs and their effectiveness and tolerability in a sample of patients with PD in a two-month treatment course...
  3. ncbi request reprint The 35% CO2 hyperreactivity and clinical symptomatology in patients with panic disorder after 1 week of treatment with citalopram: an open study
    A Bertani
    Department of Neuropsychiatric Sciences, University of Milan, Istituto Scientifico HS Raffaele, Italy
    J Clin Psychopharmacol 21:262-7. 2001
    ..These results confirm that the serotonergic system plays an important role in the modulation of CO2 hyperreactivity and suggest an early anxiolytic effect of citalopram in patients who have panic disorder and are hyperreactive to CO2...
  4. ncbi request reprint Does the brain noradrenaline network mediate the effects of the CO2 challenge?
    L Bellodi
    Anxiety Disorders Clinical and Research Unit, Department of Neuropsychiatric Sciences, Vita Salute University, Istituto Scientifico HS Raffaele, Milan, Italy
    J Psychopharmacol 17:263-4; discussion 267-8. 2003